7th Nov 2012 12:46
Sinclair IS Pharma plc
Annual General Meeting
LONDON - 7 November 2012 - Sinclair IS Pharma plc (AIM:SPH.L) ("the Company"), the international specialty pharmaceutical company, announces that at its Annual General Meeting held today all resolutions were duly passed. Full details of the proxy votes received for each resolution are now available in the investor relations area of the company's website at www.sinclairispharma.com.
Ends
Sinclair IS Pharma plc | Tel: +44 (0) 20 7467 6920 |
Chris Spooner Alan Olby Robert Taylor |
Jefferies International Limited (NOMAD and Broker) | Tel: +44 (0) 20 7029 8000 |
Nick Adams Alex Collins |
FTI Consulting | Tel: +44 (0) 20 7831 3113 |
Stephanie Cuthbert Simon Conway |
Notes to Editors:
About Sinclair IS Pharma plc - www.sinclairispharma.com
Sinclair IS Pharma is an international specialty pharmaceutical company focused on treatments in dermatology, wound care, oncology support and critical care through advanced surface technology and innovative delivery systems. The Company has a growing sales and marketing operation with a direct sales presence in the top five European markets and an extensive marketing partner network across selected developed and emerging markets.
"Safe Harbor" Statement under the US Private Securities Litigation Reform Act of 1995: Some or all of the statements in this document that relate to future plans, expectations, events, performances and the like are forward‐looking statements, as defined in the US Private Securities Litigation Reform Act of 1995. Actual results of events could differ materially from those described in the forward‐looking statements due to a variety of factors.
Related Shares:
Sinclair Pharma